Rafferty Asset Management, LLC
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1389426
New York, NY
Position in RXRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,734,126
-$1,228,323 QoQ
Shares Held
890,595
-8.1% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $408,627,656 across 136 Biotechnology names. RXRX ranks #58 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in RXRX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,734,126 | 890,595 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,962,449 | 968,814 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,660,932 | 750,191 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,802,215 | 356,169 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,165,641 | 598,420 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,025,390 | 595,472 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,453,462 | 675,791 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,331,830 | 444,244 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,875,682 | 890,239 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $10,749,105 | 1,090,173 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,449,623 | 1,104,526 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,393,485 | 320,413 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,001,379 | 449,982 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,595,676 | 596,067 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,835,676 | 172,526 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,112,135 | 136,626 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $742,126 | 103,649 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,768,645 | 395,134 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,565,163 | 68,021 | Shares | Sole | 2021-11-10 | |
| No filing history on record for this holder in this stock. | ||||||